Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Daiichi Sankyo, AstraZeneca collaborate to evaluate patritumab deruxtecan in combination with TAGRISSO in EGFR-mutated NSCLC
Daiichi Sankyo and AstraZeneca have collaborated to evaluate patritumab deruxtecan in combination with TAGRISSO in EGFR-mutated NSCLC. (Credit: Frauke Feind from Pixabay)